E2F4 and laryngotracheoesophageal cleft: E2F4 is a transcription repressor that inhibits cell proliferation and primarily mediates the anti-proliferative activity of capsaicin; the E2F4/p130 pathway has been implicated in the growth and progression of LC [46].